SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015687
Filing Date
2022-04-26
Accepted
2022-04-26 16:15:32
Documents
6
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A dice-def14a_20220607.htm DEF 14A 822228
2 GRAPHIC gpng0ij0vlc0000001.jpg GRAPHIC 9936
3 GRAPHIC gpng0ij0vlc0000005.jpg GRAPHIC 291332
4 GRAPHIC gpng0ij0vlc0000002.jpg GRAPHIC 9936
5 GRAPHIC gpng0ij0vlc0000003.jpg GRAPHIC 1039
6 GRAPHIC gpng0ij0vlc0000004.jpg GRAPHIC 381924
  Complete submission text file 0001564590-22-015687.txt   1780128
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40794 | Film No.: 22854523
SIC: 2834 Pharmaceutical Preparations